WANTAI SARS-CoV-2 IgM ELISA Kit for Qualitative Immunoenzymatic Detection of SARS-CoV-2 IgM Antibodies in Human Serum and Plasma (WANTAI SARS-CoV-2 IgM ELISA), Batches: RNCOM202006, RNCOM202007, RNCOM202008

WANTAI SARS-CoV-2 IgM ELISA Kit for Qualitative Immunoenzymatic Detection of SARS-CoV-2 IgM Antibodies in Human Serum and Plasma (WANTAI SARS-CoV-2 IgM ELISA), Batches: RNCOM202006, RNCOM202007, RNCOM202008

The WANTAI SARS-CoV-2 IgM ELISA kit is intended for the qualitative detection of specific IgM antibodies to SARS-CoV-2 in human serum and plasma samples using the enzyme-linked immunosorbent assay (ELISA) method.

Kit Contents:

• Polystyrene microplate (removable, 12 strips × 8 wells) – 1 pc
• Negative control, 0.5 mL – 1 vial
• Positive control, 0.3 mL – 1 vial
• HRP conjugate solution, 12.0 mL – 1 vial
• Sample dilution buffer, 12.0 mL – 1 vial
• WASH buffer (20× concentrate), 50.0 mL – 1 vial
• Chromogen A, 6.0 mL – 1 vial
• Chromogen B, 6.0 mL – 1 vial
• Stop solution, 6.0 mL – 1 vial
• Protective film – 1 pc
• Instructions for use – 1 copy
• Polyethylene bag for storing unused strips – 1 pc

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, WANTAI SARS-CoV-2 IgM ELISA Kit for Qualitative Immunoenzymatic Detection of SARS-CoV-2 IgM Antibodies in Human Serum and Plasma (WANTAI SARS-CoV-2 IgM ELISA), Batches: RNCOM202006, RNCOM202007, RNCOM202008, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.